These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23293201)

  • 61. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in Cerebral Hemodynamics in Patients With Cirrhosis After Liver Transplantation.
    Macías-Rodríguez RU; Ruiz-Margáin A; Cantú-Brito C; Flores-Silva DF; García-Flores OR; Cubero FJ; Larrieta-Carrasco E; Torre A
    Liver Transpl; 2018 Dec; 24(12):1673-1679. PubMed ID: 30207422
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patients with manifest hepatic encephalopathy can reveal impaired thermal perception.
    Brenner M; Butz M; May ES; Kahlbrock N; Kircheis G; Häussinger D; Schnitzler A
    Acta Neurol Scand; 2015 Sep; 132(3):156-63. PubMed ID: 25630844
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
    Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
    Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.
    Bajaj JS; Bloom PP; Chung RT; Hassanein TI; Padilla-Martinez M; Kayali Z; Rockey DC; Sasso R; Muthukumar AR; Lee WM; Denney WS; Gavis EA; Anderson C; Blankstein L; Brennan AM; Puurunen MK; Lawitz E
    Am J Gastroenterol; 2020 May; 115(5):783-785. PubMed ID: 31449156
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breath-ammonia testing of healthy subjects and patients with cirrhosis.
    Adrover R; Cocozzella D; Ridruejo E; García A; Rome J; Podestá JJ
    Dig Dis Sci; 2012 Jan; 57(1):189-95. PubMed ID: 21842240
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic value of venous blood ammonia in patients with out-of-hospital cardiac arrest.
    Kasai A; Nagao K; Kikushima K; Watanabe K; Tachibana E; Soga T; Matsuzaki M; Yagi T
    Circ J; 2012; 76(4):891-9. PubMed ID: 22313800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.
    Jiang Q; Jiang G; Shi KQ; Cai H; Wang YX; Zheng MH
    Ann Hepatol; 2013; 12(5):803-9. PubMed ID: 24018499
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence of minimal hepatic encephalopathy in cirrhotic patients.
    Maldonado-Garza HJ; Vázquez-Elizondo G; Gaytán-Torres JO; Flores-Rendón AR; Cárdenas-Sandoval MG; Bosques-Padilla FJ
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S40-4. PubMed ID: 22228880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
    Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical Manifestations of Hepatic Encephalopathy.
    Dellatore P; Cheung M; Mahpour NY; Tawadros A; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):189-196. PubMed ID: 32245526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease.
    Qureshi MO; Khokhar N; Saleem A; Niazi TK
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):135-7. PubMed ID: 24491011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.